Antitumor antibiotic BMY-41219
US5344823A · kind A · utility
3Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 1992 |
| Grant date | Sep 6, 1994 |
| Priority date | — |
| Expiry date | Feb 6, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/044
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new antitumor antibiotic designated BMY-41219 is produced by fermentation of Saccharothrix aerocolonigenes ATCC 39243. The BMY-41219 antibiotic exhibits antitumor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.